{
  "id": "5a9d99ac4e03427e73000002",
  "type": "factoid",
  "question": "What is measured with the Proseek panels?",
  "ideal_answer": "Differnet Proseek multiplex protein biomarker panels exists: CVD, inflammatory, neurology and oncology biomarker.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29026368",
    "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
    "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
    "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
    "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
    "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
    "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
    "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
    "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
    "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
    "http://www.ncbi.nlm.nih.gov/pubmed/29051715",
    "http://www.ncbi.nlm.nih.gov/pubmed/28437237"
  ],
  "snippets": [
    {
      "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " PROSEEK Multiplex CVD and PROSEEK Multiplex INF ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A multiplex proximity extension assay allowed us to measure 157 cardiovascular disease (CVD) and inflammatory disease-related biomarkers in patients from the international, multicenter, and randomized trial;",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Plasma concentrations of MMP12 were measured at baseline in 3394 subjects with high-risk for cardiovascular disease (CVD) using the Olink ProSeek CVD I array. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28734077",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120\u00a0min afterward with the Proseek Multiplex Neurology\u00a0I kit.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n\u00a0=\u00a075) and age-matched healthy control subjects (n\u00a0=\u00a023)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29026368",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Using highly-sensitive Proximity Extension ImmunoAssay on 92 cancer biomarkers (Proseek Multiplex, Olink),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29050213",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This new technology (Proseek\u00aeMultiplex Oncology Plates) can simultaneously measure the expression of 92 proteins in serum based on a proximity extension assay.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29051715",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Levels of 82 proteins were assessed in plasma by a proximity extension assay (Proseek Multiplex CVD,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "erum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Laboratory analyses were performed by Proximity Extension Assay (Proseek Multiplex CVD I(96 \u00d7 96)), ELISAs and RT-PCR.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26475405",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Differnet Proseek multiplex protein biomarker panels exists: CVD, inflammatory, neurology and oncology biomarker."
}